OSR Health OSRH
OTC OSRH
$0.15 +0.01 (+7.14%)
At close: Nov 6, 2026 · 4:00 PM EST

OSR Health (OSRH) EBITDA (2024 - 2026)

Updated

OSR Health (OSRH) posted EBITDA of -$669,973 for Q2 2026, compared with -$2.88 million a year earlier.

Analysis

OSR Health (OSRH) EBITDA (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at OSR Health was -$7.42 million; for FY2025, it came in at -$9.03 million.

  • In prior years, OSR Health's EBITDA was -$2 million in FY2024.
  • The Q2 2026 figure stands as the highest quarterly EBITDA since Q1 2025.
  • According to Business Quant data, EBITDA for the three prior quarters was -$1.24 million (Q1 2026), -$4.09 million (Q4 2025) and -$1.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,247.14 Bn 1,220.76 Bn 20.46 Bn 13.33 Bn
2 Johnson & Johnson 673.46 Bn 593.32 Bn 17.30 Bn 8.30 Bn
3 AbbVie 518.23 Bn 486.24 Bn 13.12 Bn 8.16 Bn
4 Merck 364.19 Bn 327.13 Bn 13.19 Bn 7.37 Bn
5 Novartis Ag 315.32 Bn 288.56 Bn - -
6 Astrazeneca 292.32 Bn 266.22 Bn 13.26 Bn 5.99 Bn
7 Amgen 250.73 Bn 202.39 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 210.00 Bn 185.11 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.21 Bn 114.57 Bn 12.56 Bn 7.05 Bn
10 OSR Health 4.77 Mn -2.91 Mn 86,605.00 -669,973.17
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -669,973.17
Mar 31, 2026 -1.24 Mn
Dec 31, 2025 -4.09 Mn
Sep 30, 2025 -1.42 Mn
Jun 30, 2025 -2.88 Mn
Mar 31, 2025 -644,631.29
Dec 31, 2024 -459,387.00
Sep 30, 2024 -736,132.00
Jun 30, 2024 -417,286.00
Mar 31, 2024 -389,418.00
API Access

OSR Health EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=OSRH&period=max&api_key=YOUR_API_KEY